XML 53 R42.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK-BASED COMPENSATION - Narrative (Details)
1 Months Ended 3 Months Ended
Oct. 31, 2024
tranche
shares
Jan. 31, 2023
tranche
$ / shares
shares
Mar. 31, 2025
incentivePlan
shares
Jun. 30, 2020
$ / shares
shares
Mar. 31, 2024
shares
Jun. 07, 2023
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of plans | incentivePlan     1      
Number of shares authorized (in shares)           20,100,000
Issuance of common stock upon exercise of options (in shares)     0      
Restated Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)     2,320,287      
DeepHealth Inc.            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Options granted (in dollars per share) | $ / shares       $ 16.93    
Shares issuable upon the exercise of stock options | DeepHealth Inc.            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Issuance of common stock upon exercise of options (in shares)       412,434    
Performance Based Stock Units ("PSUs")            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based payment award, award vesting period   3 years        
Granted (in shares) 35,522 60,685        
Number of vesting traches | tranche 5 2        
Shares issued per share (in dollars per share) | $ / shares   $ 18.64        
Shares issued (in shares)         121,370  
Performance Based Stock Options ("PSOs")            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based payment award, award vesting period   3 years        
Issuance of common stock upon exercise of options (in shares)   235,227        
Number of vesting traches | tranche   3        
Performance Based Stock Options ("PSOs") | Board of Directors            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares issued per share (in dollars per share) | $ / shares   $ 18.64        
Minimum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based payment award, award vesting period     3 years      
Share-based payment award, expiration period     5 years      
Minimum | Restated Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based payment award, award vesting period     3 years      
Share-based payment award, expiration period     5 years      
Minimum | Performance Based Stock Units ("PSUs")            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting rights, percentage 0.00% 0.00%        
Minimum | Performance Based Stock Options ("PSOs")            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting rights, percentage   0.00%        
Maximum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based payment award, award vesting period     5 years      
Share-based payment award, expiration period     10 years      
Maximum | Restated Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based payment award, award vesting period     5 years      
Share-based payment award, expiration period     10 years      
Maximum | Performance Based Stock Units ("PSUs")            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting rights, percentage 100.00% 200.00%        
Maximum | Performance Based Stock Options ("PSOs")            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting rights, percentage   100.00%        
Number of shares available in grant (in shares)         235,227